[Graft failure after allogeneic hematopoietic stem cell transplantation: Definition and risk factors]

Bull Cancer. 2019 Jun;106(6):574-583. doi: 10.1016/j.bulcan.2019.03.009. Epub 2019 May 4.
[Article in French]

Abstract

Allogeneic hematopoietic stem cell transplantation is the only curative therapy for numerous malignant and non-malignant haematological diseases. A sustained engraftment of the donor stem cells is essential for transplant success and overall outcome. Graft failure is a rare but severe event after allogeneic hematopoietic stem cell transplantation. While different risk factors such as underlying disease, graft source or HLA matching have been found to be consistently associated with graft failure, other factors such as ABO mismatch graft-versus-host disease prophylaxis or infections, particularly viral reactivations, are more controversial. In this article, we review the different factors associated with graft failure.

Keywords: Allogeneic hematopoietic stem cell transplantation; Allogreffe de cellules souches hématopoïétiques; Graft failure; Infections; Non-prise de greffe; Rejection; Rejet.

Publication types

  • Review

MeSH terms

  • Allografts
  • Blood Group Incompatibility
  • Disease Management
  • Graft Rejection* / epidemiology
  • Graft Rejection* / etiology
  • Graft Rejection* / immunology
  • Graft Rejection* / physiopathology
  • Graft vs Host Disease / complications
  • Graft vs Host Disease / prevention & control
  • Hematologic Diseases / therapy
  • Hematopoietic Stem Cell Transplantation* / mortality
  • Histocompatibility
  • Humans
  • Incidence
  • Neutropenia / etiology
  • Pancytopenia / etiology
  • Risk Factors
  • Transplantation Chimera